ARCHIVES

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

This article is from The Cancer Letter archive.

Vol. 23 No. 7 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: New York Legislature Votes $240 Mil. Bond Issue For Roswell Park Construction; Kripke Honored

April 25, 1992

New Clinical Trials Monitoring Program To Site Visit PIs Every Three Years

July 30, 1982

In Brief: Salmon, Fidler Head ASCO, AACR; Durant, Pardee Presidents Elect; Namovicz, Other AOs Promoted

May 25, 1984

FDA News: Rule On Youth Tobacco Sales In Effect Feb. 28

February 21, 1997

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

August 26, 2005

Coalitions Diverge On NIH Role, Agree On Need For More Basic Research

February 19, 1993